Elixir hopes to design drugs that block the effects of the natural hormone ghrelin, which prompts the release of growth hormone and stimulates appetite.
This gland is "switched off" during IVF treatment because it controls a woman's own hormone production, preventing any activity which could interfere with treatment which artificially stimulates the ovaries to release an egg.